AbbVie Inc (BSP:ABBV34)
R$ 69.32 0 (0%) Market Cap: 1.97 Til Enterprise Value: 2.37 Til PE Ratio: 62.50 PB Ratio: 52.72 GF Score: 80/100

Abbvie Inc to Host a Virtual Immunology Strategic Update Transcript

Dec 14, 2020 / 03:00PM GMT
Release Date Price: R$33.57 (-0.17%)
Operator

Good morning, and thank you for standing by. My name is Nicole, and I will be your conference operator today.

I would like to welcome everyone to the AbbVie Immunology Update Conference call. (Operator Instructions) I would now like to introduce Ms. Liz Shea, Vice President of Investor Relations.

Elizabeth Shea
AbbVie Inc. - VP of IR

Good morning, and thanks for joining us. Also on the call with me today are Rick Gonzalez, Chairman of the Board and Chief Executive Officer; Michael Severino, Vice Chairman and President; Rob Michael, Executive Vice President and Chief Financial Officer; Jeff Stewart, Executive Vice President and Chief Commercial Officer; and Elaine Sorg, Senior Vice President and President, U.S. Commercial operations.

Before we get started, I remind you to please review the forward-looking statements and disclosures on Slide 3 of our presentation. Please note that the slides being referenced during this morning's webcast will be posted on our website later this morning. With that, I'll turn the call over to Rick for

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot